Recommendations for the use of antiemetics: Evidence-based, clinical practice guidelines

被引:400
作者
Gralla, RJ [1 ]
Osoba, D [1 ]
Kris, MG [1 ]
Kirkbride, P [1 ]
Hesketh, PJ [1 ]
Chinnery, LW [1 ]
Clark-Snow, R [1 ]
Gill, DP [1 ]
Groshen, S [1 ]
Grunberg, S [1 ]
Koeller, JM [1 ]
Morrow, GR [1 ]
Perez, EA [1 ]
Silber, JH [1 ]
Pfister, DG [1 ]
机构
[1] Amer Soc Clin Oncol, Alexandria, VA 22314 USA
关键词
D O I
10.1200/JCO.1999.17.9.2971
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2971 / 2994
页数:24
相关论文
共 291 条
  • [61] METHYLPREDNISOLONE FOR THE CONTROL OF CMF-INDUCED EMESIS
    CHIARA, S
    CAMPORA, E
    LIONETTO, R
    BRUZZI, P
    ROSSO, R
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1987, 10 (03): : 264 - 267
  • [62] VARIABLES CONTRIBUTING TO ANTICIPATORY NAUSEA AND VOMITING IN CANCER-CHEMOTHERAPY
    CHIN, SBY
    KUCUK, O
    PETERSON, R
    EZDINLI, EZ
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (03): : 262 - 267
  • [63] CLARK R, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P257
  • [64] CLARK R, 1985, ONCOL NURS FORUM S, V12, P96
  • [65] ORAL ONDANSETRON IN THE PREVENTION OF CHEMOTHERAPY-INDUCED EMESIS IN BREAST-CANCER PATIENTS
    CLAVEL, M
    BONNETERRE, J
    DALLENS, H
    PAILLARSE, JM
    BONSROSSET
    BREMOND
    CAILLERES
    CHOLLET
    CORETTE
    DREYFUS
    DUTIN
    FROGER
    GOUDIER
    GUIOCHET
    KOHN
    LAPLAIGE
    LEBOURGEOIS
    LEJEUNE
    LEROL
    MANDET
    MARTY
    MAYLEVIN
    MELLE
    MIGNOT
    MORVAN
    OBERLING
    OLIVIER
    PATRICOT
    POUILLART
    PREVOT
    PUJADELAURAINE
    RENAUD
    RIMAILHO
    ROMIEU
    CELIGNY, S
    SUZANNE
    VEYRET
    ZYLBERBERG
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A (01) : 15 - 19
  • [66] THE MANAGEMENT OF NAUSEA AND VOMITING IN CLINICAL ONCOLOGY
    CRAIG, JB
    POWELL, BL
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1987, 293 (01) : 34 - 44
  • [67] CRENIER L, 1996, SUPPORT CARE CANCER, V4, P253
  • [68] ANTAGONISM OF SEROTONIN-S3 RECEPTORS WITH ONDANSETRON PREVENTS NAUSEA AND EMESIS INDUCED BY CYCLOPHOSPHAMIDE-CONTAINING CHEMOTHERAPY REGIMENS
    CUBEDDU, LX
    HOFFMAN, IS
    FUENMAYOR, NT
    FINN, AL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (10) : 1721 - 1727
  • [69] EFFICACY OF ONDANSETRON (GR-38032F) AND THE ROLE OF SEROTONIN IN CISPLATIN-INDUCED NAUSEA AND VOMITING
    CUBEDDU, LX
    HOFFMANN, IS
    FUENMAYOR, NT
    FINN, AL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (12) : 810 - 816
  • [70] EFFICACY OF ORAL ONDANSETRON, A SELECTIVE ANTAGONIST OF 5-HT3 RECEPTORS IN THE TREATMENT OF NAUSEA AND VOMITING ASSOCIATED WITH CYCLOPHOSPHAMIDE-BASED CHEMOTHERAPIES
    CUBEDDU, LX
    PENDERGRASS, K
    RYAN, T
    YORK, M
    BURTON, G
    MESHAD, M
    GALVIN, D
    CIOCIOLA, AA
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1994, 17 (02): : 137 - 146